Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

Status:
Completed

Trial end date:
2003-10-01

Target enrollment:

Participant gender:

This trial is to compare PB127 echocardiography to other heart imaging studies.

Phase 3

Point Biomedical